AMYLYX PHARMACEUTICALS INC

Ticker: AMLX CUSIP: 03237H101 Class: Common Stock

Nantahala Capital Management, LLC's Holding History (CIK: 0001472322)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 835,684 Value ($000) $10,095 Avg Close $13.58 Range $11.69 - $16.96
Q3 2025
Shares 935,684 Value ($000) $12,716 Avg Close $9.41 Range $5.97 - $15.14
Q2 2025
Shares 2,934,405 Value ($000) $18,810 Avg Close $4.86 Range $3.11 - $6.70
Q1 2025
Shares 2,934,405 Value ($000) $10,388 Avg Close $3.56 Range $2.60 - $4.18
Q4 2024
Shares 1,452,153 Value ($000) $5,489 Avg Close $4.71 Range $2.91 - $7.27
Q3 2024
Shares 1,404,564 Value ($000) $4,551 Avg Close $2.25 Range $1.62 - $3.33
Q4 2023
Shares 620,110 Value ($000) $9,128 Avg Close $15.33 Range $11.82 - $18.88
Q3 2023
Shares 407,205 Value ($000) $7,456 Avg Close $21.15 Range $17.80 - $25.48
Q2 2023
Shares 164,500 Value ($000) $3,548 Avg Close $27.01 Range $20.79 - $31.77